CRISTI CAMPBELL: Open Payments
NPI 1326196767 · CAMERON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 23 payments from 9 companies in 2025. Trend: 2023 $405 · 2024 $427 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $97 |
| Viatris Specialty LLC | 5 | $96 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Astellas Pharma US Inc | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: YUPELRI, FANAPT, Veozah, MOUNJARO, ZEPBOUND, CAPLYTA, Auvelity, UBRELVY.
Industry payments across MO — which companies pay providers there.
